-
Caixia Dong1,2,Yuwei Ding1,2,3,Shanshan Weng1,2,Guichao Li4,Yanqing Huang2,3,Hanguang Hu1,2,3,Zhen Zhang4,Suzhan Zhang2,3,5,Ying Yuan1,2,3(Department of Medical Oncology,The Second Affiliated Hospital of Zhejiang University School of Medicine;Cancer Center,Zhejiang University;Cancer Institute,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,The Second Affiliated Hospital of Zhejiang University School of Medicine;Department of Radiation Oncology,Fudan University Shanghai Cancer Hospital;Department of Colorectal Surgery,The Second Affiliated Hospital of Zhejiang University School of Medicine).Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020[J].中国癌症研究(英文版),2021,第3期
-
Hongyu Tan1,Jin Wei1,Shuo Li1,Ling Yu1,Hongwei Sun1,Ke Ji2,Yinkui Wang2,Changlong Li2(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Anesthesiology,Peking University Cancer Hospital & Institute;Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Cancer,Peking University Cancer Hospital & Institute).Pain threshold,anxiety and other factors affect intensity of postoperative pain in gastric cancer patients:A prospective cohort study[J].中国癌症研究(英文版),2021,第3期
-
Ke Zhao1,2,Xiaomei Wu3,Zhenhui Li4,Yingyi Wang5,Zeyan Xu1,Yajun Li1,Lin Wu6,Su Yao7,Yanqi Huang1,8,Changhong Liang1,Zaiyi Liu1(Department of Radiology,Guangdong Provincial People’s Hospital,Guangdong Academy of Medical Sciences;School of Medicine,South China University of Technology;Department of Radiology,the Sixth Affiliated Hospital of Sun Yat-sen University;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center;Department of Radiology,Zhuhai People’s Hospital,Zhuhai Hospital Affiliated with Jinan University;Department of Pathology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center;Department of Pathology,Guangdong Provincial People’s Hospital,Guangdong Academy of Medical Sciences;the Second School of Clinical Medicine,Southern Medical University).Prognostic value of a modified Immunoscore in patients with stage I-III resectable colon cancer[J].中国癌症研究(英文版),2021,第3期
-
Zhenli Li1,2,Geng Chen1,2,Zhixiong Cai1,2,Xiuqing Dong1,2,Lei He1,2,Liman Qiu1,2,Yongyi Zeng1,2,3,Xiaolong Liu1,2,Jingfeng Liu1,2,3(The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province,Mengchao Hepatobiliary Hospital of Fujian Medical University;Mengchao Med-X Center,Fuzhou University;Liver Disease Center,the First Affiliated Hospital of Fujian Medical University).Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns[J].中国癌症研究(英文版),2021,第3期
-
Jun Zhu,Jun Ma(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Lymphoma,Peking University Cancer Hospital & Institute;Department of Hematology & Oncology,Harbin Institute of Hematology & Oncology;Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology).Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)[J].中国癌症研究(英文版),2021,第3期
-
Yihui Tang1,Jianxian Lin1,2,Junpeng Lin1,Jiabin Wang1,2,Jun Lu1,2,Qiyue Chen1,2,Longlong Cao1,2,Mi Lin1,Ruhong Tu1,Changming Huang1,2,Ping Li1,2,Chaohui Zheng1,2,Jianwei Xie1,2(Department of Gastric Surgery,Fujian Medical University Union Hospital;Key Laboratory of Ministry of Education of Gastrointestinal Cancer,Fujian Medical University).Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma[J].中国癌症研究(英文版),2021,第3期
-
Yuting Wang1;Minjie Wang2;He Li3;Kun Chen1;Hongmei Zeng4;Xinyu Bi5;Zheng Zhu6;Yuchen Jiao1;Yong Wang7;Jian Zhu8;Hui Zhao9;Xiang Liu10;Chunyun Dai11;Chunsun Fan8;Can Zhao12;Deyin Guo13;Hong Zhao5;Jianguo Zhou5;Dongmei Wang1;Zhiyuan Wu1;Xinming Zhao6;Wei Cui2;Xuehong Zhang14,15;Jianqiang Cai5;Wanqing Chen3;Chunfeng Qu1(State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Ultrasonography, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;Qidong Liver Cancer Institute & Qidong People’s Hospital;Lingbi Center for Disease Control and Prevention;Mengcheng Center for Disease Control and Prevention;Sheyang Center for Disease Control and Prevention;Shenqiu County Center for Disease Control and Prevention;Dancheng Center for Disease Control and Prevention;Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School;Department of Nutrition, T.H. Chan School of Public Health,Harvard University).A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers[J].中国癌症研究(英文版),2021,第3期
-
Duo You1,Danfeng Du2,Xueke Zhao2,Xinmin Li3,Minfeng Ying1,Xun Hu1(Cancer Institute (Key Laboratory for Cancer Intervention and Prevention,China National Ministry of Education,Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences),The Second Affiliated Hospital,Zhejiang University School of Medicine;State Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory of Esophageal Cancer Research of the First Affiliated Hospital,Zhengzhou University;Department of Pathology,Women and Infants Hospital of Zhengzhou).Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia[J].中国癌症研究(英文版),2021,第3期
-
Yuankai Shi1,Qingyuan Zhang2,Xiaohong Han1,Yan Qin1,Xiaoyan Ke3,Hang Su4,Li Liu5,Jinxiang Fu6,Jie Jin7,Jifeng Feng8,Xiaonan Hong9,Xiaohong Zhang10,Depei Wu11,Bin Jiang12,Xiaodong Dong13(National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;Harbin Medical University Cancer Hospital;Peking University Third Hospital;The 307th Hospital of Military Chinese People’s Liberation Army;Tangdu Hospital of the Fourth Military Medical University;The Second Affiliated Hospital of Soochow University;The First Affiliated Hospital Zhejiang University College of Medicine;Jiangsu Cancer Hospital;Fudan University Shanghai Cancer Center;The Second Affiliated Hospital Zhejiang University School of Medicine;The First Affiliated Hospital of Soochow University;Peking University People’s Hospital;Shanghai Henlius Biotech,Inc.).Phase 1 studies comparing safety,tolerability,pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma[J].中国癌症研究(英文版),2021,第3期
-
Hengyu Chen1,Zhe Su1,Ruoyan Li1,Ning Zhang2,3,Hua Guo2,Fan Bai1,3(Biomedical Pioneering Innovation Center (BIOPIC),School of Life Sciences,Peking University;Laboratory of Cancer Cell Biology,Tianjin Medical University Cancer Institute and Hospital;Translational Cancer Research Center,First Hospital,Peking University).Single-cell DNA methylome analysis of circulating tumor cells[J].中国癌症研究(英文版),2021,第3期
-
Wenlin Chen,Delin Liu,Penghao Liu,Ziren Kong,Yaning Wang,Yu Wang,Wenbin Ma(Department of Neurosurgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College).Current evidence and challenges of systematic therapies for adult recurrent glioblastoma:Results from clinical trials[J].中国癌症研究(英文版),2021,第3期
-
Yi He1,Chang Gao2,Ying Pang1,Jixiang Chen3,Lili Tang1(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Psycho-oncology,Peking University Cancer Hospital & Institute;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Outpatient,Chinese Academy of Medical Sciences and Peking Union Medical College;Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital & Institute).Psychosomatic symptoms affect radiotherapy setup errors in early breast cancer patients[J].中国癌症研究(英文版),2021,第3期
-
You Duo,Du Danfeng,Zhao Xueke,Li Xinmin,Ying Minfeng,Hu Xun.Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1alpha under hypoxia[J].中国癌症研究,2021,第3期
-
Xiaohan Fan,Xiangxiang Qin,Yang Zhang,Zhexuan Li,Tong Zhou,Jingying Zhang,Weicheng You,Wenqing Li,Kaifeng Pan(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital & Institute).Screening for gastric cancer in China:Advances,challenges and visions[J].Chinese Journal of Cancer Research,2021,第2期
-
Bin Ke,Han Liang(Department of Gastric Cancer,Tianjin Medical University Cancer Institute and Hospital,Tianjin Key Laboratory of Cancer Prevention and Therapy,Tianjin’s Clinical Research Center for Cancer,National Clinical Research Center for Cancer).Current status of lymph node dissection in gastric cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Hongyan Cheng1,2,Shang Wang1,2,Wenqing Luan1,2,Xue Ye1,2,Sha Dou1,Zhijian Tang1,Honglan Zhu1,Peter Ping Lin3,Yi Li1,Heng Cui1,2,Xiaohong Chang1,2(Department of Obstetrics and Gynecology,Peking University People’s Hospital;Center of Gynecologic Oncology,Peking University People’s Hospital;Cytelligen).Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Sheng Ao1,2,Yuchen Wang1,Qingzhi Song1,Yingjiang Ye2,Guoqing Lyu1(Department of Gastrointestinal Surgery,Peking University Shenzhen Hospital;Department of Gastrointestinal Surgery,Peking University People’s Hospital).Current status and future perspectives on neoadjuvant therapy in gastric cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Jiyang Li1,2,Shaoqing Li1,Hongqing Xi1,Peifa Liu1,Wenquan Liang1,Yunhe Gao1,Chuang Wang1,Bo Wei1,Lin Chen1,Yun Tang1,Zhi Qiao1(Department of General Surgery,the First Medical Center,Chinese PLA General Hospital;Liposuction Center of Plastic Surgery Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College).Effect of preoperative nutrition therapy type and duration on short-time outcomes in gastric cancer patient with gastric outlet obstruction[J].Chinese Journal of Cancer Research,2021,第2期
-
Sung Gon Kim,Bang Wool Eom,Hong Man Yoon,Chan Gyoo Kim,Myeong-Cherl Kook,Young-Woo Kim,Keun Won Ryu(Center for Gastric Cancer,Research Institute & Hospital,National Cancer Center).Recent updates and current issues of sentinel node navigation surgery for early gastric cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Wenhao Luo1,Jiangdong Qiu1,Lianfang Zheng2,Taiping Zhang1,3(Department of General Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Nuclear Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;Clinical Immunology Center,Chinese Academy of Medical Sciences and Peking Union Medical College).Novel therapies targeting hypoxia mechanism to treat pancreatic cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Quan Wang1,2,Zhu Wang3,Zhen Zhang1,2,Wei Zhang1,2,Mengmeng Zhang1,2,Zhanlong Shen1,2,Yingjiang Ye1,2,Kewei Jiang1,2,Shan Wang1,2(Department of Gastroenterological Surgery,Peking University People’s Hospital;Laboratory of Surgical Oncology,Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research,Peking University People’s Hospital;Department of Gastrointestinal Surgery,Shandong Provincial Hospital Affiliated to Shandong First Medical University).Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing[J].Chinese Journal of Cancer Research,2021,第2期
-
Hanfei Guo,Wenqian Li,Lei Qian,Jiuwei Cui(Cancer Center,the First Hospital of Jilin University).Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Jiahui Chen,Zhaode Bu,Jiafu Ji(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Cancer,Peking University Cancer Hospital & Institute).Surgical treatment of gastric cancer:Current status and future directions[J].Chinese Journal of Cancer Research,2021,第2期
-
So Hyun Kang1,Hyung-Ho Kim1,2(Department of Surgery,Seoul National University Bundang Hospital;Department of Surgery,Seoul National University College of Medicine).Laparoscopic surgery for gastric cancer:Current status and future direction[J].Chinese Journal of Cancer Research,2021,第2期
-
Huiping Li1,Cuizhi Geng2,Hongmei Zhao3,Hanfang Jiang1,Guohong Song1,Jiayang Zhang1,Yaxin Liu1,Xinyu Gui1,Jing Wang1,Kun Li1,Zhongsheng Tong4,Fangyuan Zhao5,Junlan Yang6,Guoliang Chen7,Qianyu Liu7,Xu Liang1(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital & Institute;Breast Disease Diagnostic and Therapeutic Center,the Fourth Affiliated Hospital of Hebei Medical University;Department of General Surgery,Peking University Third Hospital;Department of Breast Oncology,Key Laboratory of Breast Cancer Prevention and Therapy,National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital;Department of the Public Health Sciences,University of Chicago;Department of Medical Oncology,Chinese PLA General Hospital;Jiangsu Hengrui Medicine Co.Ltd.).Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis[J].Chinese Journal of Cancer Research,2021,第2期
-
Satoru Matsuda1,Tomoyuki Irino1,Hirofumi Kawakubo1,Hiroya Takeuchi2,Yuko Kitagawa1(Department of Surgery,Keio University School of Medicine;Department of Surgery,Hamamatsu University School of Medicine).Current status and challenges in sentinel node navigation surgery for early gastric cancer[J].Chinese Journal of Cancer Research,2021,第2期
-
Tongchao Zhang1,Hui Chen2,3,Xiaolin Yin1,Qiufeng He1,Jinyu Man1,Xiaorong Yang2,3,Ming Lu1,2,3(Department of Epidemiology and Health Statistics,School of Public Health,Cheeloo College of Medicine,Shandong University;Clinical Epidemiology Unit,Qilu Hospital of Shandong University;Clinical Research Center of Shandong University).Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions:Findings from Global Burden of Disease Study[J].Chinese Journal of Cancer Research,2021,第1期
-
Jiachen Zhou1,2,Rongshou Zheng2,Siwei Zhang2,Hongmei Zeng2,Shaoming Wang2,Ru Chen2,Kexin Sun2,Minjuan Li2,Jianhua Gu2,Guihua Zhuang1,Wenqiang Wei2(Department of Epidemiology and Biostatistics,School of Public Health,Xi’an Jiaotong University Health Science Center;National Central Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College).Colorectal cancer burden and trends:Comparison between China and major burden countries in the world[J].Chinese Journal of Cancer Research,2021,第1期
|